Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

52 results about "Flemingia macrophylla" patented technology

Flemingia macrophylla a is woody leguminous shrub belonging to the genus Flemingia. It is a multipurpose plant widely used in agriculture, crop improvement, fodder, dyes and for various therapeutic purposes. Perhaps, it is the most versatile species of Flemingia in terms of adaptation, medicinal and agricultural applications.

Method for extracting genistin from largeleaf flemingia

The invention relates to a method for extracting genistin from largeleaf flemingia. The method comprises the following steps: (1) chopping the raw material largeleaf flemingia and performing reflux extraction by use of ethanol water having the concentration of 50-70% to obtain an extract; (2) concentrating the extract obtained in the step (1) and putting on a chromatographic column, wherein the fixed phase in the chromatographic column is macroporous adsorption resin; eluting with an ethanol-water solution in the volume ratio of (15-25): (85-75) as a moving phase and collecting the eluate; and (3) concentrating the eluate obtained in the step (2) into a thick extract, adding ethanol containing 2-3% of glacial acetic acid for thorough dissolving, standing, filtering out insoluble substances, recrystallizing the filtrate, washing crystals by use of ethanol, and drying in vacuum to obtain the genistin. The method has the advantages of rich and easily available raw materials, simple and feasible process, low pollution and short period; and the obtained product is high in purity and prone to large-scale preparation.
Owner:ZHUZHOU QIANJIN PHARMA

Luoshiteng medicated liquor

The present invention discloses trachelospermum divarcatum medicinal liquor for effectively curing the diseases of rheumatic lumbago and seclalgia, traumatic injuries, rheumatic arthritis, rheumatalgia, arthralgia due to wind-cold-dampness and hemiplegia, etc. it is made up by using Chinese medicinal material trachelospermum divarcatum, erycibe obtusifolia, xueshanlin, flemingia macrophylla root, rubia yunnanensis and white liquor.
Owner:蓝子花

[Compositions and methods containing natural compounds from nonconventional sources that are useful in maintaining normal blood sugar levels]

InactiveUS20060003035A1Maintain blood sugar levelsBiocideUnknown materialsNormal glucose levelCitrus medica
The invention describes compositions and methods containing nonconventional plant materials, and more particularly the species Flemingia macrophylla and Careya arborea, that help to maintain normal blood sugar levels in humans and animals. The method of preparation of such compositions and methods of quantifying active principles therein are also described. A Metformin-like compound were found to be the active hypoglycemic principle in Flemingia macrophylla and Careya arborea root bark. The compositions of the invention were found to be safe for therapeutic use.
Owner:SAMI LABS LTD

Method for trapping and killing tea lesser leafhoppers with plant repellent and attractant in push-pull manner

ActiveCN109769813AEfficient lureHas repellent propertiesBiocidePest attractantsFlemingia macrophyllaLeafhopper
The invention provides a method for trapping and killing tea lesser leafhoppers with a plant repellent and an attractant in a push-pull manner. The 41-51mg / mL attractant is prepared from the followingvolatile matters from branches and leaves of flemingia macrophylla at a proportion: cis-3-hexen-1-ol, cis-3-hexen-acetic ester, ocimene, methyl salicylate, cis-3-hexen-butyric ester, dodecane, hexadecane and nonanal. The 15-25mg / mL of two-component repellent is prepared from the following ingredients at a proportion: thymol and 2-isopropyl-4-methyl anisole. The tea lesser leafhoppers prevail frommid-May to mid-July and from September to November every year, a lure loaded with the repellent is bound in tea bushes during prevailing, and the leafhoppers are repelled out by the repellent; meanwhile, a bud green sticky board with an attractant lure is fixed above the tea bushes, and the leafhoppers are attracted to the sticky board by the attractant; 15-20 sets of 'push-pull' combinations areplaced per mu, so that a large amount of leafhoppers are trapped and killed, and green prevention and control can be achieved.
Owner:CHINA JILIANG UNIV

Traditional Chinese medicine composition for treating impotence and preparation method thereof

The invention discloses a traditional Chinese medicine composition for treating impotence and a preparation method thereof. The traditional Chinese medicine composition disclosed by the invention comprises the following ingredients in parts by weight: 30-60 parts of bitter cardamon, 30-60 parts of flemingia macrophylla, 30-60 parts of raspberry, 20-50 parts of mistletoe, 20-50 parts of achyranthes root and 10-20 parts of dragon bone. The traditional Chinese medicine composition disclosed by the invention can be prepared into any clinically-acceptable oral pharmaceutical preparation according to conventional traditional Chinese medicine preparation methods. The traditional Chinese medicine composition disclosed by the invention has the effects of invigorating the spleen, benefiting the liver and kidney, stopping emission and invigorating yang; and shown by clinical treatment effects, the traditional Chinese medicine composition disclosed by the invention has definite and reliable treatment effects on impotence, treats both symptoms and root causes, is safe in clinical application and is free of any toxic and side effect.
Owner:叶立新

Traditional Chinese medicine composition for treating sciatica

The invention discloses a traditional Chinese medicine composition for treating sciatica. The traditional Chinese medicine composition is composed of the following raw materials in parts by weight: 2-4 parts of salviae miltiorrhizae, 5-7 parts of schisandra chinensis, 3-4 parts of radix rehmanniae preparata, 2-4 parts of euphorbia kansui, 4-6 parts of kadsura pepper stem, 1-3 parts of scorpio, 3-5 parts of cortex Illicii, 8-10 parts of cistanche, 6-8 parts of erycibe obtusifolia benth, 1-3 parts of elaeagnus oldhamii maxim, 2-3 parts of myoporum bontioides, 4-6 parts of rhizoma drynariae, 2-4 parts of cortex acanthopanacis, 5-7 parts of lycopodium clavatum, 5-7 parts of Sichuan lovage rhizome, 1-2 parts of flemingia macrophylla, 2-3 parts of saururus chinensis, 3-5 parts of radix angelicae sinensis, 1-3 parts of iiex asprella and 2-4 parts of justicia gendarussa; the traditional Chinese medicine composition disclosed by the invention has the functions of relieving rigidity of muscles and activating collaterals, promoting blood circulation to remove blood stasis, inducing menstruation to relieve menalgia, dispelling wind and eliminating dampness, and the like, has a better effect on expelling wind-damp and freeing the channels and network vessels, can be used for effectively treating sciatica, and is convenient to use, significant in treatment effect and free of any toxic or side effect.
Owner:刘刚

Traditional Chinese medicine powder for treating postoperative upper limb edema of breast cancer and nursing method

The invention discloses traditional Chinese medicine powder for treating postoperative upper limb edema of a breast cancer. Traditional Chinese medicine believes the disease is caused by injuried blood vessels and nerves to result in unsmooth qi and blood circulation, subcutaneous water flow, blood stasis and internal retention, a patient has insufficient vital qi originally, and vitality is injured by postoperative radiotherapy and chemotherapy, and the patient is incapable of promoting blood circulation to result in the blood stasis, phlegm dampness and retention, thereby causing the disease. Accordingly, the traditional Chinese medicine powder adopts begonia fimbristipula, clinacanthus nutans, a discadenoid cherry root, gynura divaricata, a dichrocephala root, clerodendrum indicum, splendid achnatherum, desmodium heterocarpon, flemingia macrophylla, a radix fici simplicissimae root, railway beggarticks herb, and primrose willow which are ground, bagged and heated for external application. Clinical trials show the powder has a total effective rate up to 93.33%, and a significant curative effect.
Owner:康静霞

Culture medium for increasing contents of flavonoid compound and polysaccharide of moghania macrophylla tissue culture seedlings

The invention discloses a culture medium for increasing contents of flavonoid compound and polysaccharide of moghania macrophylla tissue culture seedlings. The culture medium is prepared from the following raw materials of sugar, ginkgetin, potassium salt, phosphor salt, nitrogen salt, calcium salt, magnesium salt, iodine salt, boron salt, molybdenum salt, zinc salt, manganese salt, copper salt, iron salt, vitamins, amino acids, auxin, gibberellin, succinimide, cytokinin, kinetin, a conditioner, a dispersant, a synergist, a stabilizer, an antibacterial agent and water. The culture medium for the moghania macrophylla tissue culture seedlings has the advantages that the compounding is reasonable, the comprehensive nutrients are realized, the root promoting and stem producing can be quickly performed, and the transplanting survival rate is increased; the accumulation of the flavonoid compound and the polysaccharide is promoted, and the economic benefit is increased.
Owner:LUSHAN COLLEGE OF GUANGXI UNIV OF SCI & TECH

Obstruction removal and analgesic external application drug bag

The invention provides an obstruction removal and analgesic external application drug bag. A drug composition comprises the following raw materials: a lespedeza buergeri root, a lindera glauca root, radix clematidis, a macaque bone, a philippine flemingia root, a mysore thorn seed grub, a spider, a cockroach, marmot fat, silkworm droppings, wild rhizoma et radix notopterygii, procumbent gynura, a centella aslatlca urban leaf, tribulus terrestris, a negundo chastetree leaf, catmint, a glaucescent fissistigma root, eel blood, glabrous sarcandra glabrous herb, semen vaccariae, Chinese fevervine herb, bark of girald daphne, methyl methionine, caulis sinomenii, borneol and herba geranii. The obstruction removal and analgesic external application drug bag opens muscular interstices by virtue of a thermal force, clears pores, facilitates blood circulation and accelerates skin absorption to a drug, so that a treatment effect is improved; the effect is significant; the therapy efficacy is high; and the drug bag has no toxic or side effect.
Owner:广西南宁医网情深科技有限公司

Traditional Chinese medicine for curing liver-kidney asthenia femoral head necrosis and preparation method thereof

The invention provides a traditional Chinese medicine for curing liver-kidney asthenia femoral head necrosis and a preparation method thereof. The traditional Chinese medicine comprises the following crude drugs: membranaceous beautyleaf roots, giantleaf ardisia rhizome, Aristolochia impressinervis C. F. Liang, black sesame seeds, adenia chevali, mussel, roots of wallich swallowwort, flatstem astragalus seeds, Lindera metcalfiana Allen var.dictyophylla (Allen) H. P. Tsui, asiatic bilberry, winter creeper, herb of whixh plant, sambucus adnata, pyrola, the old green, Flemingia macrophylla (Willd.) Prain, byttneria aspera colebr and stems of manyflower fissistigma. The traditional Chinese medicine has an exact curative effect on liver-kidney asthenia femoral head necrosis, and has small toxic and side effects.
Owner:韦标方

Bagged oral medicinal tea for treating lumbar muscle strain

The invention relates to traditional Chinese medicine tea, in particular to bagged oral medicinal tea for treating lumbar muscle strain. The medicinal tea is prepared from the following raw materials: 40-45g of rhizoma atractylodis, 40-45g of cortex phellodendri, 35-40g of peach leaf, 35-40g of delavay stephania root, 45-50g of moghania macrophylla root and 50-55g of tea leaves. The bagged oral medicinal tea provided by the invention has the characteristics of novel formula of raw materials, quick absorption and good effect, and is easy to prepare and convenient to use.
Owner:平南县科学技术情报研究所

Traditional Chinese medicine preparation capable of treating third lumbar transverse process syndrome

The invention discloses a traditional Chinese medicine preparation capable of treating third lumbar transverse process syndrome. According to the theory of the traditional Chinese medicine, the symptom cause of third lumbar transverse process syndrome is external evil, or stumble, falling, sudden sprain and contusion, and the root cause is kidney deficiency. In the traditional Chinese medicine preparation provided by the invention, the traditional Chinese medicinal materials with the efficacies of expelling wind and removing cold, eliminating dampness and heat, invigorating blood circulation and easing pain, and nourishing liver and kidney, such as grossedentate clematis root, ardisia villosa, heterophyllous wing seedtree root, Ficus erecta Thumb.var.beecheyana (Hook.et Arn.) King [F.beecheyana Hook.et Arn.], flemingia macrophylla (willd.) prain, polygonum cuspidatum, goldhair hedyotis herb, morinda officinalis, eclipta, glossy privet fruits, Chinese holly, and Schisandra lancifolia(Rehd.et.Wils)A.C.Smith[S.sphenantheraRehd,etWils.var.lanci-folia Rehd.et.Wils are adopted, and decocted by water to prepare the decoction. Through the clinical test, the total effective rate achieves 97.5%, which is obviously superior to that the control group, and thus the traditional Chinese medicine preparation is worthy of popularization and application.
Owner:杨士柏

Traditional Chinese medicine for treating pulmonary emphysema and preparation method thereof

The invention discloses a traditional Chinese medicine for treating pulmonary emphysema and a preparation method thereof. The traditional Chinese medicine is prepared from the following medicinal materials in parts by weight: 6-19 parts of caulis polygoni multiflori, 3-12 parts of Chinese yam, 5-15 parts of lagotis brevituba Maxim, 4-19 parts of flemingia macrophylla, 7-18 parts of hoodshaped alocasia rhizome, 1-9 parts of spica schizonepetae, 14-28 parts of radix glycyrrhizae, 11-23 parts of senecio scandens, 5-19 parts of semen brassicae, 9-25 parts of radix wikstroemae, 4-19 parts of potentilla chinensis, 10-29 parts of schisandra chinensis, 3-17 parts of mahonia japonica, 10-25 parts of ligusticum wallichii, 3-11 parts of perilla fruit, 5-15 parts of cortex moutan, 10-24 parts of fructus corni and 9-20 parts of radix paeoniae alba. According to the traditional Chinese medicine for treating pulmonary emphysema and the preparation method thereof, provided by the invention, the natural traditional Chinese medicine raw materials are adopted, so that the traditional Chinese medicine is simple and convenient to prepare, wide in medicinal raw material sources, and low in cost, and further has the advantages of obvious curative effect, little side effect, low cost and the like.
Owner:范明月

Traditional Chinese medicine composition for treating flaccidity syndrome caused by artories and veims stasis

The invention discloses a traditional Chinese medicine composition for treating a flaccidity syndrome caused by artories and veims stasis. The traditional Chinese medicine composition is characterized by being prepared from the following medicinal materials in parts by weight: 8 parts of martianus dermestoides chevr, 50 parts of flemingia macrophylla root, 12 parts of kadsura pepper stem, 15 parts of girald acanthopanax bark, 12 parts of radix dipsaci, 14 parts of fritsch's briggsia, 12 parts of hedyotis ampliflora hance, 12 parts of loose knot, 15 parts of ligularia hodgsoni hook, 15 parts ofgreywhitehair raspberry roots and leaves, 12 parts of arachnoid cyanotis root, 14 parts of obcordate raspberry root, 25g of psilate catchweed bedstraw herb, 30g of climbing entada, 12g of fewleaf schnabelia herb and 8 parts of of liquorice. The traditional Chinese medicine composition disclosed by the invention is used for treating the flaccidity syndrome caused by artories and veims stasis, is high in effective rate, reliable in curative effect, and free of recurrence after healing.
Owner:李杰

Dai medicinal compound extract for preventing and treating Alzheimer disease and application of Dai medicinal compound extract

The invention discloses a Dai medicinal compound extract, which is processed and prepared from sambucus chinensis, entada phaseoloides, crinum asiaticum, flemingia macrophylla and iberis umbellate. The Dai medicinal compound extract can be used for preventing and treating Alzheimer disease. The invention further discloses application of the Dai medicinal compound extract in preparation of a healthcare product and a medicine for preventing and treating the Alzheimer disease. The Dai medicinal compound extract disclosed by the invention is good in curative effect, fewer in toxic and side effects, cheap in price, and suitable for wide popularization in clinic.
Owner:HEILONGJIANG UNIV OF CHINESE MEDICINE

Mixed forestation method for improving economic values of rubber plantation

InactiveCN109716994AImprove the economic benefits of productionImprove survival rateClimate change adaptationFertilising methodsShort termsAquilaria sinensis
The invention provides a mixed forestation method for improving economic values of a rubber plantation. The method includes the steps of rubber and aquilaria sinensis mixed pattern determination, mixed forestation young growth (4-5 years after mixed forestation) pineapple, radix curcuma and flemingia macrophylla short-term herbal or under-shrub economic crop forest intercropping and young forest tending. The forestation method is simple, high in plant percent, good in growth trait expression and high in economic benefit at a mixed forestation young stand stage and has good improvement effectsof decreasing soil loss, improving soil fertility, improving water retaining capacity, increasing biological diversity, building multilayer multiple rubber compound ecological systems and controllingor relieving rubber tree disease and insect damage.
Owner:KUNMING INST OF BOTANY - CHINESE ACAD OF SCI

Meat duck feed for reducing feces nitrogen and phosphorus emission

The invention discloses a meat duck feed for reducing feces nitrogen and phosphorus emission. The feed is prepared from the following raw materials: royal jelly, broussonetia papyrifera leaves, hybridarmy grass, flemingia macrophylla, desmodium gangeticum, mulberry leaves, moringa oleifera leaves, allicin, konjac gum, tamarind gum, reduced isomaltooligosaccharide, yeast selenium, chlorella, perilla oil, loofah sponge, bamboo shoot shells, monoglycerides, a microbial preparation, a cellulase preparation, a xylanase preparation and composite vitamins. The feed is prepared by fermentation, extrusion granulation and is fed after being blended with a common concentrate. The feed is good in palatability and easy to digest and absorb, the emission of nitrogen and phosphorus in meat duck feces isremarkably reduced, and the pressure of a farm on the surrounding environment is greatly reduced. The feed is simple to prepare and can be produced and applied in a large scale.
Owner:广西汇创牧业有限公司

Traditional Chinese medicine liquid for whitening and removing freckles and detoxifying and beautifying

The invention discloses a traditional Chinese medicine liquid for whitening and removing freckles and detoxifying and beautifying. The traditional Chinese medicine liquid is characterized in that the preparation method comprises the following steps: placing 5 parts of giantleaf ardisia rhizome, 15 parts of red oak barks, 5 parts of common hogfennel roots, 15 parts of Japanese ardisia herb, 5 parts of nervilia fordii, 15 parts of flemingia macrophylla, 5 parts of semen litchi, 15 parts of balsamiferou blumea herb and 5 parts of fructus viticis in a medicine boiler; adding clean water which meets the standard of domestic drinking water, wherein the water addition is based on exceeding 2-3cm of the medicine level; soaking the traditional Chinese medicines for half a hour to fully lubricant the traditional Chinese medicines to fully decoct the liquid medicine; boiling by high heat and then decocting for 20 minutes by soft fire; and removing dregs and taking a soup. The traditional Chinese medicine liquid disclosed by the invention can inhibit the activity of tyrosinase and expand blood capillaries, increase blood circulation, accelerate metabolism of skins and reduce deposition of stains and pigments, so that chloasma pigments are removed or desalinated.
Owner:施维华

Traditional Chinese medicine for treating cell cheilitis

The invention discloses a traditional Chinese medicine for treating cell cheilitis. The traditional Chinese medicine consists of the following Chinese herbal medicines: herba saxifragae stoloniferae, fructus gardeniae, common sage herb, fructus bruceae, fragile blueberry fruit, herba urenae lobatae , radix polygalae fallacis, root of flemingia macrophylla, cissus pteroclada hayata, cissus modecoides planch. var. subintegra gagn, Chinese arborvitae resin, bark of Indian jujube, root of spine aralia, rhizoma drynariae, flos rosae sinensis, tsinling larkspur root and radix gynurae segeti. The traditional Chinese medicine disclosed by the invention, which is prepared from the pure natural Chinese herbal medicines, is capable of treating both symptoms and root causes, and the traditional Chinese medicine is concrete in curative effect, free from toxic and side effects and free from easy reoccurrence.
Owner:胡金凤

A kind of preparation method of phenylpropanoid compound

The invention relates to the technical field of medicines, discloses a preparation method of a phenylpropanoid compound, and particularly relates to a phenylpropanoid compound which is obtained by being separated from dried roots of moghania macrophylla (Willd.) O Ktze.. The phenylpropanoid compound is prepared through the steps of solvent extraction, column chromatographic separation and liquid phase preparation, separation and purification. The phenylpropanoid compound obtained through the method is reported for the first time and is high in purity. It is proved through experiments that the obtained novel phenylpropanoid compound can inhibit expression effects of cell inflammatory factors of TNF-alpha, IL-1 beta and IL-6, has an inhibiting effect on hydroxyl free radicals (-OH), has anti-inflammatory and antioxidant activities, is beneficial for treatment of various inflammatory diseases such as cervicitis, endometritis, pelvic inflammation, mastitis, faucitis and / or arthritis and can be developed into a novel drug. The compound is the phenylpropanoid compound with the structural formula as shown in a formula (I) and pharmaceutically acceptable salts thereof. Please see the formula (I) in the description.
Owner:ZHUZHOU QIANJIN PHARMA

Preparation method of phenylpropanoid compound

The invention relates to the technical field of medicine and discloses a preparation method of a phenylpropanoid compound. The invention particularly relates to a method for separating a phenylpropanoid compound from dried root of flemingia macrophylla, and the phenylpropanoid compound is prepared by steps of solvent extraction, column chromatography separation and preparation of liquid-phase separation for purification. The phenylpropanoid compound obtained by the method disclosed by the invention is reported for the first time and has high purity. Proven by experiments, the obtained new phenylpropanoid compound has an effects on inhibiting the content of cell inflammatory factor NO, inhibiting expression of cell inflammatory factors IL-1 beta and IL-6 and inhibiting hydroxyl free radical (-OH), thereby having anti-inflammatory and oxidation resisting activities and benefiting treatment of cervicitis, endometritis, pelvic inflammation, mastitis, faucitis and / or arthritis and various inflammatory diseases. The phenylpropanoid compound can be developed into a new drug. The structural formula of the phenylpropanoid compound disclosed by the invention is as shown in formula (I) in the specification.
Owner:ZHUZHOU QIANJIN PHARMA

Preparation method of phenylpropanoid compound

The invention discloses a preparation method of a phenylpropanoid compound, and relates to the technical field of medicine, in particular to a phenylpropanoid compound separated from dried roots of flemingia macrophylla. The compound is prepared through the steps of solvent extraction, column chromatography separation, liquid phase preparation, and separation and purification. The compound obtained through the method is reported for the first time and is high in purity. Experiments prove that the obtained phenylpropanoid compound can restrain the content of the inflammatory cytokine NO and then achieve anti-inflammatory activity by restraining NO approaches, is beneficial to treatment of various inflammatory diseases such as cervicitis, endometritis, pelvic inflammation, mastitis, sphagitis and / or arthritis, and can be developed into new medicine. The structural formula of the phenylpropanoid compound and medically-acceptable salt thereof is the formula (I) in the description.
Owner:ZHUZHOU QIANJIN PHARMA

Ecological cultivation method for preventing and controlling weeds by intercropping amorphophallus konjac and flemingia macrophylla

The invention discloses an ecological cultivation method for preventing and controlling weeds by intercropping amorphophallus konjac and flemingia macrophylla. The ecological cultivation method comprises the following steps: selection of a planting field; selection of seed stems; land preparation and farmyard manure application; standard cultivation; and disease and pest control. The growth environment of an amorphophallus konjac planting field is protected, soil pollution is reduced, the output value per mu is increased, and benefits are increased.
Owner:FUYUAN JINDI KONJAK SEED IND

Preparation method of phenylpropanoid compound

The invention relates to the technical field of medicines, discloses a preparation method of a phenylpropanoid compound, and particularly relates to a phenylpropanoid compound which is obtained by being separated from dried roots of moghania macrophylla (Willd.) O Ktze.. The phenylpropanoid compound is prepared through the steps of solvent extraction, column chromatographic separation and liquid phase preparation, separation and purification. The phenylpropanoid compound obtained through the method is reported for the first time and is high in purity. It is proved through experiments that the obtained novel phenylpropanoid compound can inhibit expression effects of cell inflammatory factors of TNF-alpha, IL-1 beta and IL-6, has an inhibiting effect on hydroxyl free radicals (-OH), has anti-inflammatory and antioxidant activities, is beneficial for treatment of various inflammatory diseases such as cervicitis, endometritis, pelvic inflammation, mastitis, faucitis and / or arthritis and can be developed into a novel drug. The compound is the phenylpropanoid compound with the structural formula as shown in a formula (I) and pharmaceutically acceptable salts thereof. Please see the formula (I) in the description.
Owner:ZHUZHOU QIANJIN PHARMA

Traditional Chinese medicine for treating cold evil stagnation type heel pain

The invention discloses a traditional Chinese medicine for treating cold evil stagnation type heel pain. The traditional Chinese medicine is prepared from the following medicinal materials in parts by weight: 8 parts of aristolochia impressinervis, 12 parts of pubescent pepper herb, 15 parts of rhizome of coronarious gingerlily, 6 parts of thelephora vialis, 12 parts of allophylus viridis radlk, 15 parts of lasianthus chinensis, 12 parts of impatiens pinfanens hook, 15 parts of storaxleaf artocarpus root, 25 parts of largeleaf flemingia root, 30 parts of beechey fig leaf, 15 parts of aucuba himalaica hook, 15 parts of viscum multinerve, 25 parts of lithocarpus polystachyus, 8 parts of largeleaf curculigo rhizome, 10 parts of Tsingling bergenia rhizome and 5 parts of licorice root. The traditional Chinese medicine disclosed by the invention can be used for effectively treating the cold evil stagnation type heel pain. According to the use effect of multiple patients for years, the traditional Chinese medicine has the advantages of effective rate as high as 100 percent, cure rate as high as 97 percent, good treatment effect and no relapse after the diseases are cured.
Owner:青岛祥翔生物医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products